top of page
tokers-guide-find-the-best-weed-in-dc-lo
NEW 1 to 1 photo editing 122024 (17).png
A coalition of anti-marijuana groups has sued the Trump administration to block a new initiative allowing federal health insurance programs to cover hemp-derived CBD and THC products. The lawsuit alleges the program violates administrative and federal laws by bypassing public comment and providing coverage for substances that lack FDA approval.

New Legal Battle: Anti-Cannabis Groups Fight to Stop Federal Coverage for Hemp-Derived CBD and THC

Mar 31, 2026

Source:

Kyle Jaeger

Marijuana Moment

The fight for affordable cannabis access just hit a major snag in federal court. A group of anti-cannabis organizations, led by Smart Approaches to Marijuana (SAM), has filed a lawsuit to stop a groundbreaking initiative that would provide Medicare coverage for hemp-derived CBD and THC products. This program, orchestrated by the Centers for Medicare & Medicaid Services (CMS) under the current administration, was set to launch this week, offering eligible patients up to $500 annually for these wellness products.

The lawsuit argues that CMS skipped necessary public comment periods and is essentially authorizing "unapproved" medicine. For everyday tokers and the seniors who rely on these products for chronic pain or cancer symptoms, this legal hurdle is a frustrating setback. The program was designed to bring high-quality, tested hemp solutions—like those from reputable partners like Charlotte’s Web—directly to patients through their doctors. By integrating cannabis into federal health insurance, the initiative aimed to legitimize the plant’s medical utility and make it accessible to those on fixed incomes.

Why does this matter to the community? It’s about the shift from "gas station snake oil" to regulated, medical-grade options that are actually covered by insurance. If the program survives this legal challenge, it could set a massive precedent for how cannabis is treated in the healthcare system, especially as we move toward federal rescheduling to Schedule III.

For now, the best move for enthusiasts and patients is to stay informed about local hemp laws, as they are rapidly changing. If you or a loved one are on Medicare and were hoping to utilize this $500 incentive, keep an eye on the court’s decision regarding the temporary restraining order. In the meantime, continue sourcing your CBD from transparent brands that provide third-party lab results (COAs) to ensure you're getting exactly what’s on the label. Accessibility is the goal, and while the legal road is bumpy, the momentum toward integrating cannabis into mainstream wellness continues. Stay hopeful and stay lifted!

Recent Reviews

bottom of page